 Geneva, Switzerland and Boston, MA March 3, 2021 ObsEva SA NASDAQ: OBSV SIX: OBSN, a biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health, today announced that Company Management will provide a corporate update and participate in one-on-one investor meetings at the upcoming H.C. Wainwright Global Life Sciences Conference to be held March 9-10, 2021. 